BioCorRx (BICX) EBITDA Margin Growth (1y) (2012 - 2026)
BioCorRx (BICX) EBITDA Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn | 532.00 |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn | -169.00 |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn | 609.00 |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn | 49.00 |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn | -974.00 |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn | 35.00 |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn | 9.00 |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn | 622.00 |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn | -264.00 |
| 10 | BioCorRx | 10,406.16 | -374,763.84 | 189,355.00 | 24,811.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24,811.00 |
| Jun 30, 2025 | 3.29 Mn |
| Mar 31, 2025 | 2.59 Mn |
| Jun 30, 2024 | -2.89 Mn |
| Mar 31, 2024 | -2.40 Mn |
| Dec 31, 2023 | -288,747.00 |
| Sep 30, 2023 | -833,518.00 |
| Jun 30, 2023 | 365,780.00 |
| Mar 31, 2023 | 285,322.00 |
| Dec 31, 2022 | 831,980.00 |
| Sep 30, 2022 | 1.74 Mn |
| Jun 30, 2022 | -237,534.00 |
| Mar 31, 2022 | 1.01 Mn |
| Dec 31, 2021 | -182,453.00 |
| Sep 30, 2021 | -1.16 Mn |
| Jun 30, 2021 | 29,489.00 |
| Mar 31, 2021 | -1.14 Mn |
| Dec 31, 2020 | -537,152.00 |
| Sep 30, 2020 | -497,239.00 |
| Jun 30, 2020 | -394,725.00 |